Cell & Gene therapy continues to be one of fastest growing spaces in life sciences with RNA dominating a lot of innovations in genetic medicine. There are now over 800 RNA based therapeutics and vaccines already in early stage clinical development across mRNA, RNAi, antisense oligonucleotides and wider nucleic acids. AGS Therapeutics is delighted to be a Silver Sponsor for this 2024 event.

Vaccines leaders, experts and distinguished scientists in Europe, delivering breakthrough research, technologies & connecting global pharma, biotech and academia, meet for high-level discussions on the latest innovations within the vaccines discovery, therapeutics & manufacturing.

Partnerships and debates on critical issues facing the biotech industry today. Bio€quity Europe, 20 years of network gathering rendez-vous for CEOs and investors. This year's program is focused on how to create a new playbook for biotech success in Europe.

Europe’s springtime partnering event for the global life science community. 3 days in-person, March 20–22, 2023 - Basel, Switzerland | 3 days virtually, March 28–30, 2023 - Digital.

Two full days focused on the last RNA developments: scientific, clinical and commercial development of RNA therapeutics and vaccines.

25th year of the program, fueling the biotech industry as a premier event for C-Suite leaders and the investor and banking communities, focused on established and emerging publicly traded and select private biotech companies.

Development of innovative strategies against infectious diseases in a multidisciplinary approach.

RNA communication across kingdoms: new mechanisms and strategies in pathogen control (exRNA-PATH).

Biomanufacturing in the biopharmaceutical production sector.

Regenerative Medecine: Cell therapy, biomaterials and tissue engineering.